UPDATE: Xenon Pharmaceuticals (XENE) PT Raised to 35% to $31 at Stifel Ahead of Key Data
Tweet Send to a Friend
(Updated - April 26, 2021 8:24 AM EDT)
Stifel analyst Paul Matteis raised the price target on Xenon Pharmaceuticals ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Stifel analyst Paul Matteis raised the price target on Xenon Pharmaceuticals ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
